INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST/INSTITUTIONAL INVESTOR MEET27-05-2022
27-05-2022
INDOCO REMEDIES LTD. - 532612 - DISCLOSURE OF RELATED PARTY TRANSACTIONS FOR THE HALF YEAR ENDED 31.03.2022
DISCLOSURE OF RELATED PARTY TRANSACTIONS FOR THE HALF YEAR ENDED 31.03.202227-05-2022
Buy Indoco Remedies; target of Rs 510: ICICI Direct
ICICI Direct is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 510 in its research report dated May 18, 2022.19-05-2022
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of Audited Financial Results for the Quarter and Year ended 31st March, 202218-05-2022
Yes Securities sees over 35% upside on this pharma stock
On back of strong growth prognosis, Indoco remains one of its top stock picks in pharma18-05-2022
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Audio recording of Conference Call held on May 17, 202218-05-2022
Earnings Call for Q4FY22 of Indoco Remedies
Conference Call with Indoco Remedies Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.17-05-2022
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Audio recording of Conference Call held on May 17, 202217-05-2022
INDOCO REMEDIES LTD. - 532612 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for Financial year ended 31.03.202217-05-2022
